{"id":"https://openalex.org/W2043988586","doi":"https://doi.org/10.2147/jbm.s33380","title":"Treatments for chronic myeloid leukemia: a qualitative systematic review","display_name":"Treatments for chronic myeloid leukemia: a qualitative systematic review","alternate_titles":[],"publication_year":2012,"publication_date":"2012-08-01","ids":{"openalex":"https://openalex.org/W2043988586","doi":"https://doi.org/10.2147/jbm.s33380","mag":"2043988586","pmid":"https://pubmed.ncbi.nlm.nih.gov/22915985","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3419508"},"language":"en","primary_location":{"id":"doi:10.2147/jbm.s33380","doi":"https://doi.org/10.2147/jbm.s33380","is_oa":true,"landing_page_url":"https://doi.org/10.2147/jbm.s33380","pdf_url":"https://www.dovepress.com/getfile.php?fileID=13545","source":{"id":"https://openalex.org/S2765050986","display_name":"Journal of Blood Medicine","issn_l":"1179-2736","issn":["1179-2736"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","norway-1","oarl","poland-100","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Blood Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2043988586"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=13545","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113776784","display_name":"Stephen Mitchell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephen Mitchell","raw_affiliation_strings":["Abacus International, Bicester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abacus International, Bicester, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073782000","display_name":"Ferdinand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ferdinand","raw_affiliation_strings":["Pfizer, Tadworth, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Tadworth, UK","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110083060","display_name":"Tumur","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tumur","raw_affiliation_strings":["Pfizer, Tadworth, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Tadworth, UK","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030327324","display_name":"Sarah Batson","orcid":"https://orcid.org/0009-0006-4062-5648","observed_orcids":["https://orcid.org/0009-0006-4062-5648"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sarah Batson","raw_affiliation_strings":["Abacus International, Bicester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abacus International, Bicester, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2320,"currency":"USD","value_usd":2320},"apc_paid":{"value":2320,"currency":"USD","value_usd":2320},"fwci":0.9408,"has_fulltext":true,"cited_by_count":61,"citation_normalized_percentile":{"value":0.65568022,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"3","issue":null,"first_page":"51","last_page":"51"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":1.0},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.9950000047683716},{"id":"https://openalex.org/keywords/nilotinib","display_name":"nilotinib","score":0.9100000262260437},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":1.0},{"id":"https://openalex.org/keywords/bosutinib","display_name":"bosutinib","score":1.0},{"id":"https://openalex.org/keywords/second-generation-tkis","display_name":"second-generation TKIs","score":0.9309999942779541},{"id":"https://openalex.org/keywords/imatinib-resistance","display_name":"imatinib resistance","score":0.8410000205039978},{"id":"https://openalex.org/keywords/imatinib-intolerance","display_name":"imatinib intolerance","score":0.9670000076293945},{"id":"https://openalex.org/keywords/complete-cytogenetic-response","display_name":"complete cytogenetic response","score":0.8339999914169312},{"id":"https://openalex.org/keywords/major-molecular-response","display_name":"major molecular response","score":0.9089999794960022},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.7419999837875366},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8289999961853027},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.3070000112056732},{"id":"https://openalex.org/keywords/accelerated-phase-cml","display_name":"accelerated phase CML","score":0.597000002861023},{"id":"https://openalex.org/keywords/blast-phase-cml","display_name":"blast phase CML","score":0.9869999885559082}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9263781309127808},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.7814679145812988},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3700324296951294},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3457688093185425},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32469403743743896},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27924174070358276},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.2147/jbm.s33380","doi":"https://doi.org/10.2147/jbm.s33380","is_oa":true,"landing_page_url":"https://doi.org/10.2147/jbm.s33380","pdf_url":"https://www.dovepress.com/getfile.php?fileID=13545","source":{"id":"https://openalex.org/S2765050986","display_name":"Journal of Blood Medicine","issn_l":"1179-2736","issn":["1179-2736"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","norway-1","oarl","poland-100","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Blood Medicine","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2425819","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3419508","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3419508","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3419508/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Blood Med","raw_type":"Text"},{"id":"pmid:22915985","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22915985","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of blood medicine","raw_type":"Journal Article"},{"id":"pmh:oai:dovepress.com/10614","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/treatments-for-chronic-myeloid-leukemia-a-qualitative-systematic-revie-peer-reviewed-article-JBM","pdf_url":"https://www.dovepress.com/article/download/10614","source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Review"},{"id":"pmh:oai:doaj.org/article:10c17424c24d45c18c67c744f2d7202f","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/10c17424c24d45c18c67c744f2d7202f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Blood Medicine, Vol 2012, Iss default, Pp 51-76 (2012)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.2147/jbm.s33380","doi":"https://doi.org/10.2147/jbm.s33380","is_oa":true,"landing_page_url":"https://doi.org/10.2147/jbm.s33380","pdf_url":"https://www.dovepress.com/getfile.php?fileID=13545","source":{"id":"https://openalex.org/S2765050986","display_name":"Journal of Blood Medicine","issn_l":"1179-2736","issn":["1179-2736"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","norway-1","oarl","poland-100","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Blood Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2043988586.pdf","grobid_xml":"https://content.openalex.org/works/W2043988586.grobid-xml"},"referenced_works_count":67,"referenced_works":["https://openalex.org/W209719701","https://openalex.org/W1523946531","https://openalex.org/W1963731492","https://openalex.org/W1965429870","https://openalex.org/W1970962784","https://openalex.org/W1971940453","https://openalex.org/W1983852790","https://openalex.org/W1987316203","https://openalex.org/W1994309500","https://openalex.org/W1998593414","https://openalex.org/W1999494567","https://openalex.org/W2004492241","https://openalex.org/W2016960626","https://openalex.org/W2021648831","https://openalex.org/W2025935458","https://openalex.org/W2028959752","https://openalex.org/W2029573515","https://openalex.org/W2032224060","https://openalex.org/W2038161969","https://openalex.org/W2039201527","https://openalex.org/W2039531591","https://openalex.org/W2039949576","https://openalex.org/W2044901721","https://openalex.org/W2053310263","https://openalex.org/W2057206328","https://openalex.org/W2057718276","https://openalex.org/W2057796192","https://openalex.org/W2061440903","https://openalex.org/W2070683532","https://openalex.org/W2080125373","https://openalex.org/W2085358525","https://openalex.org/W2090767358","https://openalex.org/W2091005492","https://openalex.org/W2097799776","https://openalex.org/W2107268345","https://openalex.org/W2115626434","https://openalex.org/W2116153687","https://openalex.org/W2117356576","https://openalex.org/W2143939343","https://openalex.org/W2168633862","https://openalex.org/W2172189430","https://openalex.org/W2223423195","https://openalex.org/W2253507027","https://openalex.org/W2261840157","https://openalex.org/W2281742031","https://openalex.org/W2320951883","https://openalex.org/W2325215774","https://openalex.org/W2340673163","https://openalex.org/W2467057658","https://openalex.org/W2557343987","https://openalex.org/W2559795513","https://openalex.org/W2563937343","https://openalex.org/W2565396484","https://openalex.org/W2566861500","https://openalex.org/W2586256503","https://openalex.org/W2586659163","https://openalex.org/W2590231153","https://openalex.org/W2590392935","https://openalex.org/W2591336363","https://openalex.org/W2592892140","https://openalex.org/W2594322701","https://openalex.org/W2606402799","https://openalex.org/W2906992465","https://openalex.org/W4247537009","https://openalex.org/W4299847514","https://openalex.org/W4320164613","https://openalex.org/W7220687786"],"related_works":["https://openalex.org/W2908435573","https://openalex.org/W3036412813","https://openalex.org/W2475918738","https://openalex.org/W2005580235","https://openalex.org/W4401189876","https://openalex.org/W2096285574","https://openalex.org/W2753642887","https://openalex.org/W2560232213","https://openalex.org/W2037595832","https://openalex.org/W2518220782"],"abstract_inverted_index":{"BACKGROUND:":[0],"Chronic":[1],"myeloid":[2],"leukemia":[3],"(CML)":[4],"is":[5],"a":[6,104,137,187],"myeloproliferative":[7],"disorder":[8],"of":[9,84,86,91,106,131,145,154,180,218,251,281],"blood":[10],"stem":[11],"cells.":[12],"The":[13],"tyrosine":[14],"kinase":[15],"inhibitor":[16],"(TKI)":[17],"imatinib":[18,132,175,206,289],"was":[19,33,71,184,192],"the":[20,53,61,76,89,116,121,124,181,193,210,216,219,252,264,278],"first":[21],"targeted":[22],"therapy":[23],"licensed":[24],"for":[25,52,88,277],"patients":[26,282],"with":[27,35,43,174,186,205,256],"chronic-phase":[28],"CML,":[29],"and":[30,40,58,64,80,115,156,168,212,232,271],"its":[31],"introduction":[32],"associated":[34,185],"substantial":[36],"improvements":[37],"in":[38,60,109,136,209,222,263],"response":[39,162,166,171,249],"survival":[41],"compared":[42,173,204,255],"previous":[44],"therapies.":[45],"Clinical":[46],"trial":[47,141],"data":[48,200],"are":[49,273,284],"now":[50],"available":[51],"second-generation":[54,149,182,195,220,253],"TKIs":[55,87,150,183,221,254],"(nilotinib,":[56],"dasatinib,":[57,270],"bosutinib)":[59],"first-,":[62],"second-,":[63],"third-line":[65,213],"settings.":[66],"A":[67],"qualitative":[68],"systematic":[69],"review":[70],"conducted":[72],"to":[73,128,197,244,288],"qualitatively":[74],"compare":[75],"clinical":[77],"effectiveness,":[78],"safety,":[79],"effect":[81],"on":[82],"quality":[83],"life":[85],"management":[90],"chronic-,":[92],"accelerated-,":[93],"or":[94,158,225,286],"blast-phase":[95],"CML":[96],"patients.":[97],"METHODS:":[98],"Included":[99],"studies":[100,262],"were":[101],"identified":[102],"through":[103],"search":[105],"electronic":[107],"databases":[108],"September":[110],"2011,":[111],"relevant":[112],"conference":[113],"proceedings":[114],"grey":[117],"literature.":[118],"RESULTS:":[119],"In":[120],"first-line":[122,238],"setting,":[123],"long-term":[125],"efficacy":[126,217],"(up":[127],"8":[129],"years)":[130],"has":[133],"been":[134],"confirmed":[135,215],"single":[138],"randomized":[139,239],"controlled":[140,240],"(International":[142],"Randomized":[143],"Study":[144],"Interferon":[146],"[IRIS]).":[147],"All":[148],"reported":[151],"lower":[152],"rates":[153,172,250],"transformation,":[155],"comparable":[157],"superior":[159,248],"complete":[160,169],"cytogenetic":[161],"(CCyR),":[163],"major":[164],"molecular":[165,170],"(MMR),":[167],"by":[176,230],"2-year":[177,245],"follow-up.":[178],"Each":[179],"distinct":[188],"adverse-event":[189],"profile.":[190],"Bosutinib":[191],"only":[194],"TKI":[196],"report":[198],"quality-of-life":[199],"(no":[201],"significant":[202,279],"difference":[203],"treatment).":[207],"Data":[208,236],"second-":[211],"setting":[214,266],"either":[223],"imatinib-resistant":[224],"-intolerant":[226],"patients,":[227],"as":[228],"measured":[229],"CCyR":[231],"MMR":[233],"rates.":[234],"CONCLUSION:":[235],"from":[237,260],"trials":[241],"reporting":[242],"up":[243],"follow-up":[246],"indicate":[247],"imatinib.":[257],"Current":[258],"evidence":[259],"single-arm":[261],"second-line":[265],"confirm":[267],"that":[268],"nilotinib,":[269],"bosutinib":[272],"valuable":[274],"treatment":[275],"options":[276],"subgroup":[280],"who":[283],"intolerant":[285],"resistant":[287],"treatment.":[290]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2043988586","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
